Methods to prevent stress remodeling of atrial tissue
View Patent ↗Methods and devices are disclosed herein for therapeutically treating atrial tissue to lessen the effects of mechanical stress on atrial tissue, where reducing mechanical stress in the portion of atrial tissue reduces formation of at least one arrhythmia substrate. In one example, the devices and methods are suitable for minimally invasive surgery. More particularly, methods and devices described herein permit creating an ablation pattern on an organ while reducing excessive trauma to a patient.
1. A method of coagulating tissue to create a bi-atrial coagulation pattern on a first and a second atrial surfaces of a cardiac tissue, where the first atrial surface and the second atrial surface are located on opposite sides of the cardiac tissue, the method comprising:
identifying at least one region of cardiac tissue subject to mechanical stress produced as a result of an adverse medical condition;
positioning a first coagulation device adjacent to the first atrial surface of the cardiac tissue;
creating a first coagulation pattern on the first atrial surface with the first coagulation device, where the first coagulation pattern results in a reduction of mechanical stress on a portion of the cardiac tissue;
positioning a second coagulation device adjacent to the second atrial surface of the cardiac tissue by determining a position of the second coagulation device through the cardiac tissue from the first atrial surface;
creating a second coagulation pattern on second surface with the second coagulation device, where the second coagulation pattern results in further reduction of mechanical stress on a portion of the cardiac tissue;
where reducing mechanical stress in the portion of cardiac tissue reduces formation of at least one arrhythmia substrate; and
applying a locational energy at the second atrial surface in an amount insufficient to ablate or coagulate tissue and observing the locational energy from the first atrial surface to determine the position of the second coagulation device.
2. The method of claim 1 , where second coagulation device further includes an additional energy source for applying the locational energy.
3. The method of claim 1 , further comprising a non-ablative energy device that applies the non-ablative energy.
4. The method of claim 3 , where the non-ablative energy comprises an energy selected from the group consisting of visible light, coherent light, ultraviolet light, magnetic energy, electrical energy.
5. The method of claim 1 , further comprising advancing a scope into a body where the scope comprises at least one visualization element configured to observe the locational energy from the first atrial surface and where positioning the second coagulation device comprises moving the second coagulation device in response to observing the locational energy.
6. The method of claim 1 , further comprising positioning a first sensor on the first atrial surface and positioning a second sensor on the second atrial surface at or near the position of the second coagulation device and determining a proximity between the first and second sensors determine the position of the second coagulation device on the first atrial surface.
7. The method of claim 1 , where the second coagulation lesion creates an electrical barrier across cardiac tissue without dissecting a pericardial reflection.
8. The method of claim 1 , where the first coagulation device comprises a device selected from the group consisting of an RF energy device, a laser device, an infrared heating heater device, a chemical ablation device, a cryogenic device, a microwave energy device, and a resistive heating device.
9. The method of claim 1 , where the first atrial surface comprises an epicardial surface and the second atrial surface comprises an endocardial surface.